Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands · Delayed Price · Currency is EUR 1.428
-0.010 (-0.70%)
Feb 6, 2026, 5:35 PM CET
Vivoryon Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
42.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -3.62M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 10.76M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cabka | 187.55M |
| Ctac N.V. | 125.22M |
| Holland Colours | 112.34M |
| Morefield Group | 101.04M |
| Alumexx | 39.87M |
| Value8 | 8.16M |
| Ebusco Holding | 848.00K |
| BM3EAC | 340.60K |
Vivoryon Therapeutics News
- 2 months ago - Vivoryon Therapeutics N.V. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Vivoryon Therapeutics NV (WBO:VVYN) Q3 2025 Earnings Call Highlights: Strategic Advances and ... - GuruFocus
- 2 months ago - Q3 2025 Vivoryon Therapeutics NV Earnings Call Transcript - GuruFocus
- 2 months ago - Vivoryon Therapeutics N.V. (VIVRF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Vivoryon Therapeutics NV (FRA:05Y) (H1 2025) Earnings Call Highlights: Strategic Advances Amid ... - GuruFocus
- 5 months ago - Half Year 2025 Vivoryon Therapeutics NV Earnings Call Transcript - GuruFocus
- 5 months ago - Vivoryon Therapeutics N.V. (VIVRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Vivoryon Therapeutics N.V. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha